Skip to content
Pricing
Sample Reports
Show submenu for Sample Reports
Company Report
Drug Report
Solutions
Show submenu for Solutions
Investors
Portfolio Managers
Research
Publisher Content
Resources
Show submenu for Resources
Case Studies
Demo Videos
Market Intelligence Datasets
Drug Index
FAQs
API Documentation
Company
Show submenu for Company
News & Updates
Leadership
CDD Vault
Contact Us
Login
Pricing
Sample Reports
Show submenu for Sample Reports
Company Report
Drug Report
Solutions
Show submenu for Solutions
Investors
Portfolio Managers
Research
Publisher Content
Resources
Show submenu for Resources
Case Studies
Demo Videos
Market Intelligence Datasets
Drug Index
FAQs
API Documentation
Company
Show submenu for Company
News & Updates
Leadership
CDD Vault
Contact Us
Triheptanoin
Dojolvi (triheptanoin) is a small molecule pharmaceutical. Triheptanoin was first approved as Dojolvi on 2020-06-30. Dojolvi's patent is valid until 2025-10-03 (FDA).
Trade Name
Dojolvi
Common Name
Triheptanoin
Indication
Drug Class
Glycerolipids